Supplementation with 0.05% lycopene for 8 weeks inhibited liver steatosis in high-fat-fed mice through miRNA-21 induction, which then caused Fabp7 degradation and decreased fatty acid-binding protein 7 (FABP7) expression (Ahn et al., 2012). This evidence concerns the gene FABP7 and fatty liver disease.